Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21885239 | 0.99 | MEN1 (0.33) | MEN1KMT2ATHRBRECQLBLM | |
| SCHEMBL21885340 | 0.96 | MEN1 (0.32) | MEN1KMT2ATHRBRECQLBLM | |
| SCHEMBL21885310 | 0.94 | MMP12 (0.32) | MEN1KMT2AAHRALOX5KDM4E | |
| SCHEMBL21885031 | 0.93 | MEN1 (0.33) | MEN1KMT2ATHRBRECQLBLM | |
| SCHEMBL21885338 | 0.91 | MEN1 (0.31) | MEN1KMT2ATHRBRECQLBLM | |
| SCHEMBL21885339 | 0.90 | PLA2G2A (0.31) | MEN1KMT2ATHRBRECQLBLM | |
| SCHEMBL21885321 | 0.89 | MEN1 (0.32) | MEN1KMT2ATHRBRECQLBLM | |
| SCHEMBL21885687 | 0.87 | MEN1 (0.31) | MEN1KMT2ATHRBRECQLBLM | |
| SCHEMBL21885312 | 0.86 | PLA2G2A (0.34) | MEN1KMT2ATHRBRECQLBLM | |
| SCHEMBL21885039 | 0.86 | MAPK14 (0.31) | KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11737355-B2 | Organic electroluminescence device and amine compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-11737355-B2 | Organic electroluminescence device and amine compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-20200106022-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200106022-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MAOA, PNMT, TPH1 | MEN1 1265/4885KMT2A 1236/4885THRB 2037/4885 |
| US-11737355-B2 | Organic electroluminescence device and amine compound for organic electroluminescence device | MAOA, PNMT, TPH1 | MEN1 1265/4885KMT2A 1236/4885THRB 2037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.